<?xml version="1.0" encoding="UTF-8"?>
<p>Because ZIKV and DENV have different pathogenic characteristics and tropism, special issues should be considered during the development of vaccines to these viruses, especially for prophylactic ZIKV vaccines which are currently under development by several research groups (
 <xref rid="B149" ref-type="bibr">Richner et al., 2017b</xref>; 
 <xref rid="B177" ref-type="bibr">Tebas et al., 2017</xref>; 
 <xref rid="B122" ref-type="bibr">Medina et al., 2018</xref>; 
 <xref rid="B130" ref-type="bibr">Modjarrad et al., 2018</xref>; 
 <xref rid="B212" ref-type="bibr">Zou et al., 2018</xref>).
</p>
